APA (7th ed.) Citation

CC, B., M, L., J, K., H, C., N, S., L, W., . . . PR, H. (2025). Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma. Blood neoplasia, 3(1), 100179. https://doi.org/10.1016/j.bneo.2025.100179

Chicago Style (17th ed.) Citation

CC, Bjorklund, et al. "Mezigdomide Combined with Bortezomib Disrupts the Cell Cycle and Elicits Superior Antitumor Effects in Multiple Myeloma." Blood Neoplasia 3, no. 1 (2025): 100179. https://doi.org/10.1016/j.bneo.2025.100179.

MLA (9th ed.) Citation

CC, Bjorklund, et al. "Mezigdomide Combined with Bortezomib Disrupts the Cell Cycle and Elicits Superior Antitumor Effects in Multiple Myeloma." Blood Neoplasia, vol. 3, no. 1, 2025, p. 100179, https://doi.org/10.1016/j.bneo.2025.100179.